Page last updated: 2024-08-26

lysophosphatidic acid and Precancerous Conditions

lysophosphatidic acid has been researched along with Precancerous Conditions in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amneus, MW; Anantharamaiah, GM; Farias-Eisner, G; Farias-Eisner, R; Fogelman, AM; Gao, F; Grijalva, V; Hough, G; Imaizumi, S; Kozak, KR; Navab, M; Ng, C; Reddy, ST; Su, F; Van Lenten, BJ; Wagner, A	1

Other Studies

1 other study(ies) available for lysophosphatidic acid and Precancerous Conditions

Article	Year
Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer. Proceedings of the National Academy of Sciences of the United States of America, 2010, Nov-16, Volume: 107, Issue:46 Topics: Animals; Apolipoprotein A-I; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Drinking Behavior; Female; Humans; Injections; Lysophospholipids; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Transplantation; Ovarian Neoplasms; Peptides; Precancerous Conditions; Survival Analysis; Tumor Burden; Water	2010

Article

Year

Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer.

Proceedings of the National Academy of Sciences of the United States of America, 2010, Nov-16, Volume: 107, Issue:46

Topics: Animals; Apolipoprotein A-I; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Drinking Behavior; Female; Humans; Injections; Lysophospholipids; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Transplantation; Ovarian Neoplasms; Peptides; Precancerous Conditions; Survival Analysis; Tumor Burden; Water

2010